Market Cap 229.29M
Revenue (ttm) 0.00
Net Income (ttm) -61.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 268,500
Avg Vol 267,026
Day's Range N/A - N/A
Shares Out 33.42M
Stochastic %K 5%
Beta N/A
Analysts Strong Sell
Price Target $37.25

Latest News on MBX

MBX Biosciences Announces Additions to Leadership Team

Mar 5, 2025, 8:00 AM EST - 4 weeks ago

MBX Biosciences Announces Additions to Leadership Team


MBX Biosciences to Participate in March Investor Conferences

Feb 18, 2025, 8:00 AM EST - 6 weeks ago

MBX Biosciences to Participate in March Investor Conferences


MBX Biosciences shares surge 44% in blockbuster Nasdaq debut

Sep 13, 2024, 12:36 PM EDT - 7 months ago

MBX Biosciences shares surge 44% in blockbuster Nasdaq debut


MBX Biosciences raises $163.2 mln in US IPO

Sep 12, 2024, 7:20 PM EDT - 7 months ago

MBX Biosciences raises $163.2 mln in US IPO


MBX Biosciences Announces Pricing of Initial Public Offering

Sep 12, 2024, 7:11 PM EDT - 7 months ago

MBX Biosciences Announces Pricing of Initial Public Offering


MBX Biosciences Announces Launch of Initial Public Offering

Sep 9, 2024, 6:30 AM EDT - 7 months ago

MBX Biosciences Announces Launch of Initial Public Offering


MBX Biosciences IPO Registration Document (S-1)

Aug 23, 2024, 4:44 PM EDT - 7 months ago

MBX Biosciences IPO Registration Document (S-1)